Flore's formulation intelligence is grounded in real-world data from our own cohorts and in published, peer-reviewed research. What follows is what we've observed and the studies behind the rationale. This is real-world evidence — observational, uncontrolled, and largely self-reported. No statement here is a disease claim.

Systems

Real-world outcomes (self-reported)Across our paired real-world cohort (n=651), 47.4% of tracked symptom-instances resolved over the course of personalized formulation, and in our separate tolerability cohort (n=18,383) 95.1% of customers remained complaint-free. This is observational, self-reported real-world evidence — not a controlled trial, and not a disease claim.

Gastrointestinal The Regular One

Strains: Bifidobacterium animalis ssp. lactis + Bifidobacterium longum

Rationale (mechanistic, not measured)Bifidobacterium fermentation of fiber to short-chain fatty acids supports motility and mucosal-barrier integrity.

Study: Martoni CJ, et al. Impact of a probiotic product on bowel habits in functional constipation. J Dig Dis. 2019;20(9):478–487. PMID 31271261. pubmed.ncbi.nlm.nih.gov/31271261

Mood / Neurological The Bright One

Strains: Bifidobacterium animalis ssp. lactis + Lactiplantibacillus plantarum

Rationale (mechanistic, not measured)Gut–brain-axis modulation of tryptophan metabolism and vagal signaling.

Study: Hidalgo-Cantabrana C, et al. Lactiplantibacillus plantarum HEAL9 improves cognition in moderately stressed subjects. Nutrients. 2023;15(15):3466. PMID 37571403. pubmed.ncbi.nlm.nih.gov/37571403

Joint / Musculoskeletal The Mighty One

Strains: Bifidobacterium animalis ssp. lactis + Bifidobacterium bifidum

Rationale (mechanistic, not measured)Anti-inflammatory rationale matching the observed arthritis/fibromyalgia signal.

Immune The Strong One

Strains: Lactobacillus acidophilus + Bifidobacterium longum

Rationale (mechanistic, not measured)GALT priming and secretory-IgA support.

Study: Leyer GJ, et al. Probiotic effects on cold and influenza-like symptom incidence in children. Pediatrics. 2009;124(2):e172–179. PMID 19651563. pubmed.ncbi.nlm.nih.gov/19651563

Skin The Clear One

Strains: Lactobacillus salivarius + Bifidobacterium animalis ssp. lactis

Metabolic The Lean One

Strains: Bifidobacterium animalis ssp. lactis + Streptococcus thermophilus

No within-subject resolution data in the cohort — mechanistic / structure-function only.

Study: Stenman LK, et al. Probiotic with or without fiber controls body fat mass in overweight adults. EBioMedicine. 2016;13:190–200. PMID 27810310. pubmed.ncbi.nlm.nih.gov/27810310

Focus & Calm The Calm One

Strains: Bifidobacterium animalis ssp. lactis + Limosilactobacillus reuteri

Mechanism / structure-function only (preclinical gut–brain rationale; autism-spectrum cohort noted).

Study: Billeci L, et al. Effects of probiotics on electroencephalography in preschoolers with autism. Autism. 2023;27(3):814–827. PMID 35362336. pubmed.ncbi.nlm.nih.gov/35362336

Women's The Radiant One

Strains: Lactobacillus gasseri + Lactobacillus fermentum

Supports vaginal pH; no symptom-resolution data.

Study: Tomusiak A, et al. Efficacy and safety of a vaginal probiotic product containing L. fermentum + L. gasseri. Drug Des Devel Ther. 2015;9:5345–5354. PMID 26451088. pubmed.ncbi.nlm.nih.gov/26451088

Boosters — Tolerability

These are complaint / tolerability rates, not efficacy. Overall baseline complaint rate: 4.87% (n=18,383).

Booster Type Complaint rate Target
Clear Skin (botanical) Botanical booster 4.0% Skin
Digest Ease Personalized booster 4.3% GI motility
Metabolic Fire Personalized booster 4.5% Metabolic
Anti-Inflammatory (botanical) Botanical booster 5.1% Systemic
Defense Plus Personalized booster 5.5% Immune
Joint Ease Personalized booster 5.7% Joint
Gut Seal Personalized booster 5.9% Barrier
Mood Lift Personalized booster 6.0% Mood
Skin Glow Personalized booster 6.2% Skin
Stress Shield Personalized booster 6.3% Stress
Focus Fuel Personalized booster 6.8% Cognitive
Flora Balance Personalized booster 9.8% Vaginal pH

Methodology

Figures are drawn from a paired real-world cohort (n=651; 1,379 symptom-instances) tracked across ~6.6-month median intervals and followed longitudinally out to 20 months, a tolerability cohort (n=18,383), and a sequencing cohort (n=14,704). Analyses used McNemar's test with Benjamini–Hochberg FDR correction. This is real-world evidence, not a controlled trial.

Peer-Reviewed Publication

Published in mSystems · American Society for Microbiology · 2024

Phan J, Calvo DC, Nair D, Jain S, Montagne T, Dietsche S, Blanchard K, Treadwell S, Adams J, Krajmalnik-Brown R. Precision synbiotics increase gut microbiome diversity and improve gastrointestinal symptoms in a pilot open-label study for autism spectrum disorder. mSystems. 2024;9(5):e00503-24. PMID 38661344. doi.org/10.1128/msystems.00503-24

Conducted in collaboration with Arizona State University. A pilot open-label study (not a randomized controlled trial) — we say so plainly.

Foundational References

  • Hill C, et al. ISAPP consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514.
  • Sanders ME, et al. Probiotics and prebiotics in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2019;16(10):605–616.

References

  1. Martoni CJ, et al. Impact of a probiotic product on bowel habits in functional constipation. J Dig Dis. 2019;20(9):478–487. PMID 31271261. pubmed.ncbi.nlm.nih.gov/31271261
  2. Hidalgo-Cantabrana C, et al. Lactiplantibacillus plantarum HEAL9 improves cognition in moderately stressed subjects. Nutrients. 2023;15(15):3466. PMID 37571403. pubmed.ncbi.nlm.nih.gov/37571403
  3. Leyer GJ, et al. Probiotic effects on cold and influenza-like symptom incidence in children. Pediatrics. 2009;124(2):e172–179. PMID 19651563. pubmed.ncbi.nlm.nih.gov/19651563
  4. Stenman LK, et al. Probiotic with or without fiber controls body fat mass in overweight adults. EBioMedicine. 2016;13:190–200. PMID 27810310. pubmed.ncbi.nlm.nih.gov/27810310
  5. Billeci L, et al. Effects of probiotics on electroencephalography in preschoolers with autism. Autism. 2023;27(3):814–827. PMID 35362336. pubmed.ncbi.nlm.nih.gov/35362336
  6. Tomusiak A, et al. Efficacy and safety of a vaginal probiotic product containing L. fermentum + L. gasseri. Drug Des Devel Ther. 2015;9:5345–5354. PMID 26451088. pubmed.ncbi.nlm.nih.gov/26451088
  7. Hill C, et al. ISAPP consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514.
  8. Sanders ME, et al. Probiotics and prebiotics in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2019;16(10):605–616.

Press & Media

Press & media — for product samples, founder interviews, or clinical data briefings, contact support@flore.com

These statements have not been evaluated by the Food and Drug Administration. Flore products are not intended to diagnose, treat, cure, or prevent any disease.